VKTX gets UBS target
VKTX is rallying violently with moderate volatility as a UBS price target and SUNRISE trial news for VK2735 draw buyers, while volume stays around normal.
Sources: https://www.boerse-express.com/news/articles/viking-therapeutics-aktie-startet-sunrise-fuer, https://www.ad-hoc-news.de/boerse/news/nebenwerte/ubs-sets-usd-94-target-for-viking-therapeutics-stock
Previous verdicts for VKTX
- AI Search: Viking Therapeutics Rallies Sharply With No Clear Fresh Catalyst — 2026-11-09
- AI Search: Viking Therapeutics Rallies Against Market Selloff on Passive Stake — 2026-11-06
- Analyst split weighs — 2026-11-05
- AI Search: Viking Therapeutics Rallies Sharply as Squeeze Drives the Move — 2026-10-29
- AI Search: Viking Therapeutics Slips Modestly Amid Profit Taking — 2026-10-23
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works